Rutgers, The State University of New Jersey: Carcinoma trials
The registry lists 11 Carcinoma studies with Rutgers, The State University of New Jersey as lead sponsor. 0 are open to participants now and 5 have results posted.
Early Phase 1 1Phase 1 2Phase 2 4No phase 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or LymphomaCompletedNCT03229278Phase 1Results posted
- Accelerated Partial Breast Radiation Therapy Using High-Dose Rate Brachytherapy in Treating Patients With Early Stage Breast Cancer After SurgeryCompletedNCT02526498Phase 2Results posted
- Cetuximab Before Surgery in Treating Patients With Aggressive Locally Advanced Skin CancerCompletedNCT02324608Not applicableResults posted
- Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck CancerTerminatedNCT02177838Not applicableResults posted
- Accelerated Radiation Therapy After Surgery in Treating Patients With Breast CancerCompletedNCT01417286Phase 2Results posted
- TAS-102 and Oxaliplatin for the Treatment of Refractory Stage IV Colon CancerActive, not recruitingNCT04294264Phase 2
- Novel Gallium Imaging in Hepatocellular CarcinomaStatus unknownNCT03116945Phase 2
- Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their PartnersCompletedNCT03112668Not applicable
- Enzalutamide Before Surgery in Treating Patients With Kidney CancerTerminatedNCT02885649Early Phase 1
- Cytoreductive Prostatectomy in Treating Patients With Newly Diagnosed, Metastatic Prostate CancerCompletedNCT02458716Phase 1
- Hypofractionated Radiation Therapy Followed by Surgery in Treating Patients With Advanced Squamous Cell Carcinoma of the Oral CavityWithdrawnNCT02295540Not applicable